N/A
Completed N=70
Helping Empower Liver and Kidney Patients
Hepatitis C · Chronic Kidney Diseases · Patient Education
Source: ClinicalTrials.gov NCT03426787 ↗
Enrolled (actual)
70
Serious AEs
0.0%
Results posted
Jul 2019
Primary outcomePrimary: Change in Knowledge — 53.54; 65.74 percentage of correct responses — p=<0.001
Summary
The overall purpose of this study is to develop and test a web-based decision aid (DA) to support patients with Hepatitis C and Chronic Kidney Disease during decisions about whether, when, and how to treat each illness. Patients will have the opportunity to learn about their hepatitis C and kidney disease, initiate thought about what matters most to them and choose a treatment plan for their liver and kidney disease that works best for them. Investigators will evaluate the tool's efficacy, usability, and the likelihood of using it in clinical practice. There are three (3) primary aims of this project: (1) to develop the DA; (2) to pilot-test the DA to determine efficacy, usability and likelihood of using it in routine practice; (3) to explore stakeholders feedback on the usefulness of the DA and likelihood of implementing the tool.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change in Knowledge |
53.54; 65.74 | <0.001 sig |
| PRIMARY Change in Decisional Conflict Scale |
2.64; 3.13 | 0.0463 sig |
| PRIMARY Change in Decision Self-Efficacy Scale |
84.42; 86.62 | >0.05 |
| SECONDARY System Usability Scale |
69.86 | — |
Eligibility Criteria
Inclusion Criteria
- Must read and understand English AND
- Must have Hepatitis C (any genotype) and Chronic Kidney Disease (any stage)
Exclusion Criteria
- Developed jaundice, ascites, variceal hemorrhage, or hepatic encephalopathy also known as Decompensated cirrhosis; or
- Currently has or had liver cancer (Hepatocellular carcinoma); or
- Received a liver transplant
Data sourced from ClinicalTrials.gov (NCT03426787). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.